148 related articles for article (PubMed ID: 23917327)
1. Immunization with recombinant leucine aminopeptidase showed protection against Fasciola gigantica in mice.
Changklungmoa N; Kueakhai P; Riengrojpitak S; Chaithirayanon K; Chaichanasak P; Preyavichyapugdee N; Chantree P; Sansri V; Itagaki T; Sobhon P
Parasitol Res; 2013 Oct; 112(10):3653-9. PubMed ID: 23917327
[TBL] [Abstract][Full Text] [Related]
2. Vaccine potential of recombinant saposin-like protein 2 against Fasciolosis gigantica in mice.
Kueakhai P; Changklungmoa N; Riengrojpitak S; Chaichanasak P; Meemon K; Chaithirayanon K; Chantree P; Sansri V; Itagaki T; Sobhon P
Vaccine; 2013 Nov; 31(47):5518-23. PubMed ID: 24075921
[TBL] [Abstract][Full Text] [Related]
3. Lack of protective efficacy in buffaloes vaccinated with Fasciola gigantica leucine aminopeptidase and peroxiredoxin recombinant proteins.
Raina OK; Nagar G; Varghese A; Prajitha G; Alex A; Maharana BR; Joshi P
Acta Trop; 2011 Jun; 118(3):217-22. PubMed ID: 21376699
[TBL] [Abstract][Full Text] [Related]
4. Vaccine potential of recombinant cathepsinL1G against Fasciola gigantica in mice.
Changklungmoa N; Phoinok N; Yencham C; Sobhon P; Kueakhai P
Vet Parasitol; 2016 Aug; 226():124-31. PubMed ID: 27514897
[TBL] [Abstract][Full Text] [Related]
5. Protection against Fasciola gigantica infection in mice by vaccination with recombinant juvenile-specific cathepsin L.
Sansri V; Meemon K; Changklungmoa N; Kueakhai P; Chantree P; Chaichanasak P; Lorsuwannarat N; Itagaki T; Sobhon P
Vaccine; 2015 Mar; 33(13):1596-601. PubMed ID: 25701317
[TBL] [Abstract][Full Text] [Related]
6. Characterization and vaccine potential of Fasciola gigantica saposin-like protein 1 (SAP-1).
Kueakhai P; Changklungmoa N; Waseewiwat P; Thanasinpaiboon T; Cheukamud W; Chaichanasak P; Sobhon P
Vet Parasitol; 2017 Jan; 233():115-122. PubMed ID: 28043381
[TBL] [Abstract][Full Text] [Related]
7. Potential of recombinant 2-Cys peroxiredoxin protein as a vaccine for Fasciola gigantica infection.
Sangpairoj K; Apisawetakan S; Changklungmoa N; Kueakhai P; Chaichanasak P; Sobhon P; Chaithirayanon K
Exp Parasitol; 2018 Nov; 194():16-23. PubMed ID: 30240576
[TBL] [Abstract][Full Text] [Related]
8. Vaccine potential of recombinant pro- and mature cathepsinL1 against fasciolosis gigantica in mice.
Kueakhai P; Changklungmoa N; Chaichanasak P; Jaikua W; Itagaki T; Sobhon P
Acta Trop; 2015 Oct; 150():71-8. PubMed ID: 26116785
[TBL] [Abstract][Full Text] [Related]
9. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep.
Maggioli G; Acosta D; Silveira F; Rossi S; Giacaman S; Basika T; Gayo V; Rosadilla D; Roche L; Tort J; Carmona C
Vaccine; 2011 Nov; 29(48):9057-63. PubMed ID: 21939713
[TBL] [Abstract][Full Text] [Related]
10. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice.
Preyavichyapugdee N; Sahaphong S; Riengrojpitak S; Grams R; Viyanant V; Sobhon P
Exp Parasitol; 2008 Jun; 119(2):229-37. PubMed ID: 18329021
[TBL] [Abstract][Full Text] [Related]
11. Vaccine potential of recombinant cathepsin B against Fasciola gigantica.
Chantree P; Phatsara M; Meemon K; Chaichanasak P; Changklungmoa N; Kueakhai P; Lorsuwannarat N; Sangpairoj K; Songkoomkrong S; Wanichanon C; Itagaki T; Sobhon P
Exp Parasitol; 2013 Sep; 135(1):102-9. PubMed ID: 23811052
[TBL] [Abstract][Full Text] [Related]
12. The combined recombinant cathepsin L1H and cathepsin B3 vaccine against Fasciola gigantica infection.
Kueakhai P; Changklungmoa N; Cheukamud W; Osotprasit S; Chantree P; Preyavichyapugdee N; Sobhon P; Meemon K
Parasitol Int; 2021 Aug; 83():102353. PubMed ID: 33872795
[TBL] [Abstract][Full Text] [Related]
13. Cytosolic superoxide dismutase can provide protection against Fasciola gigantica.
Jaikua W; Kueakhai P; Chaithirayanon K; Tanomrat R; Wongwairot S; Riengrojpitak S; Sobhon P; Changklungmoa N
Acta Trop; 2016 Oct; 162():75-82. PubMed ID: 27338185
[TBL] [Abstract][Full Text] [Related]
14. Combination Vaccines of
Changklungmoa N; Cheukamud W; Jaikua W; Meemon K; Sobhon P; Kueakhai P
Trop Med Infect Dis; 2023 Jun; 8(7):. PubMed ID: 37505630
[TBL] [Abstract][Full Text] [Related]
15. A promising new target to control fasciolosis: Fasciola hepatica leucine aminopeptidase 2.
Checa J; Salazar C; Goyeche A; Rivera M; Silveira F; Maggioli G
Vet Parasitol; 2023 Aug; 320():109959. PubMed ID: 37329826
[TBL] [Abstract][Full Text] [Related]
16. Moderate protection is induced by a chimeric protein composed of leucine aminopeptidase and cathepsin L1 against Fasciola hepatica challenge in sheep.
Ortega-Vargas S; Espitia C; Sahagún-Ruiz A; Parada C; Balderas-Loaeza A; Villa-Mancera A; Quiroz-Romero H
Vaccine; 2019 May; 37(24):3234-3240. PubMed ID: 31036453
[TBL] [Abstract][Full Text] [Related]
17. Fasciola hepatica leucine aminopeptidase, a promising candidate for vaccination against ruminant fasciolosis.
Acosta D; Cancela M; Piacenza L; Roche L; Carmona C; Tort JF
Mol Biochem Parasitol; 2008 Mar; 158(1):52-64. PubMed ID: 18178266
[TBL] [Abstract][Full Text] [Related]
18. Protection against Fasciola gigantica using paramyosin antigen as a candidate for vaccine production.
Abou-Elhakam H; Rabee I; El Deeb S; El Amir A
Pak J Biol Sci; 2013 Nov; 16(22):1449-58. PubMed ID: 24511686
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica.
Rivera F; Espino AM
Exp Parasitol; 2016 Jan; 160():31-8. PubMed ID: 26632503
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of exosome-like vesicles from Fasciola gigantica adult worm provides support for new vaccine targets against fascioliasis.
Sheng ZA; Wu CL; Wang DY; Zhong SH; Yang X; Rao GS; Peng H; Feng SW; Li J; Huang WY; Luo HL
Parasit Vectors; 2023 Feb; 16(1):62. PubMed ID: 36765398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
